Taken together, metformin treatment had no glucose-lowering and insulin sensitivity-improving effect in db/db mice with type 2 diabetes; thus, the effects observed in this study were independent of glucose and insulin plasma concentrations. The gene discussed is INS; the disease is type 2 diabetes mellitus.